Thyroseq V3 molecular testing for fine needle aspiration biopsy samples of thyroid nodules
Closed Solicitation Posted
- Solicitation number
- 75N98026Q00822
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, Office of the Director, Office of Acquisitions, seeks Thyroseq V3 molecular testing services for fine needle aspiration biopsy samples of thyroid nodules, with proposals due July 27, 2026 at 9:00 AM. This is a competitive acquisition under FAR 12.603 for commercial items, conducted using full and open competition with no set-aside, and the estimated value does not exceed the simplified acquisition threshold of $350,000.
Place of performance is Bethesda, Maryland 20892. The requirement calls for testing up to 20 thyroid nodules per year for fiscal year 2026. The contractor must perform next-generation sequencing platform testing across approximately 110 thyroid cancer-related genes to identify mutations in indeterminate samples, deliver comprehensive reports detailing identified mutations and malignancy risk assessments within two weeks of sample receipt, and supply all requisition forms and sample collection and storage equipment at no additional cost to the NCI cytopathology unit. The NAICS code is 621511 (Medical Laboratories), with a small business size standard of 41.5 million employees.
The Government will award a Firm-Fixed-Price contract to the responsible offeror whose proposal represents the best value, using a Lowest Price Technically Acceptable evaluation approach. Technical capability and price are the primary evaluation factors, along with past performance and delivery schedule. Offerors must be registered in SAM and submit unit and total pricing, shipping and handling costs, delivery timeframe, F.O.B. point (destination), product or catalog numbers, and company registration information including UEI and TIN. Responses should be submitted electronically to James.Law@nih.gov, referencing solicitation number 75N98026Q00822.
Notice text
2 versions
Update #2 · Latest ·
See attached combines Synopsis.
Update #1 ·
This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.
The solicitation number is 75N98026Q00822. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold of $350,000.00.
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a Firm-Fixed-Price to the responsible offeror whose proposal represents the best value to the Government.
The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01 March 13, 2026.
The associated NAICS code is 621511, and the small business size standard is 41,500,000 employees.
This requirement is NOT A SET-ASIDE for small businesses.
Description of Requirement:
Thyroseq testing for 20 nodules per year for the fiscal year 2026
The provision at FAR 52.212-1, Instructions to Offerors—Commercial Items, applies to this acquisition. Add any agency-specific instructions as required.
The provision at FAR 52.212-2, Evaluation—Commercial Items, applies to this acquisition.
The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation represents the best value to the Government, price and other factors considered.
Evaluation Factors:
- Technical capability
- Price
- Past performance
- Delivery schedule
A written notice of award or acceptance of an offer, issued within the time specified in the offer, shall result in a binding contract without further action by either party. The Government reserves the right to accept any offer before the expiration date.
Offerors shall include a completed copy of FAR 52.212-3, Offeror Representations and Certifications—Commercial Items, with their offer.
FAR 52.212-4, Contract Terms and Conditions—Commercial Items, applies to this acquisition.
FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders—Commercial Items, applies to this acquisition.
Submission Requirements:
Responses must include sufficient information to demonstrate the offeror’s capability to provide the required product or service. Quotes shall include, at a minimum:
- Unit and total price
- Shipping and handling costs
- Delivery timeframe after award
- Delivery terms
- F.O.B. point (destination)
- Product or catalog numbers (if applicable)
- Product/service description
Additional evaluation considerations may include past performance, warranty, lifecycle cost, maintenance availability, and environmental or energy efficiency.
Responses must include the Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. All offerors must be actively registered in the System for Award Management (SAM) at www.sam.gov.
All responses must be received by July 27, 2026 at 9:00 AM and must reference solicitation number 75N98026Q00822. Responses may be submitted electronically to James.Law@nih.gov.
Point of Contact:
James Law
James.law@nih.gov
Files
| File | Type | Posted |
|---|---|---|
| SOLICITATION.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| NOI - DNA Sequencing of Bone Marrow Failure Syndro | Office of Logisitics and Acquisition Operations | No set-aside | |
| NWI Offsite Pathology Services | Veterans Integrated Service Network 23 | Total Small Business | |
| Clinical Research Support and Collaboration for NHGRI Protocols | Office of Logisitics and Acquisition Operations | Total Small Business | |
| Q301--NEW – STX Specialized Molecular Residual Disease Testing | Veterans Integrated Service Network 17 | No set-aside | |
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity